The coronavirus (COVID-19) pandemic has affected all aspects of healthcare and the oncology and immuno-oncology communities may face unique challenges in regards to patient care. As immuno-oncology practitioners treat patients during the pandemic, it has also become apparent that the immunotherapy field may offer important insights into clinical practice, immune-related pathophysiology and other topics that may be useful to the broader healthcare community during this time of great need.
SITC is committed to providing the most current COVID-19 information and resources to its members and the oncology community at large. Resources will be updated on a regular basis throughout this rapidly evolving situation. Please continue to check back for the most current information.
In the February 2021 edition of his Fireside Chat, SITC President Patrick Hwu, MD, sat down with BioNTech CEO (and creator of the Pfizer/BioNTech SARS-CoV-2 vaccine) Ugur Sahin, MD. Dr. Hwu discussed a range of topics, including the process to develop the SARS-CoV-2 vaccine in 11 months, the role cancer immunotherapy and cancer vaccine research played in developing the vaccine and much more.
Click play on the video below to listen to the nearly 45-minute discussion.
The latest special series from JITC, COVID-19 and Cancer Immunotherapy, edited by Paolo Antonio Ascierto, MD and Jason Goldman, MD, MPH, and authored by leading voices in the immuno-oncology, infectious disease, and virology fields, is a set of authoritative reviews that serves as a valuable resource illustrating the impact COVID-19 has on cancer patients undergoing immunotherapy, providing guidance on clinical decision-making, and offering insights on the use of immunotherapy to treat COVID-19 manifestations.
EXPLORE THE SERIES
All COVID-19 content in JITC has been curated into one collection for quick, easy access to publications from researchers and clinicians across the globe.
Read more >>Insights from immuno-oncology: The Society for Immunotherapy of Cancer statement on access to IL-6-targeting therapies for COVID-19
SITC stands along with and supports our colleagues in emergency departments, intensive care units (ICUs) and inpatient wards in the global effort to overcome this unprecedented pandemic. Read more >>
COVID-19 Implications for Patient Management Forum
Purpose: Conversations directly relevant to patient care
Audience: Practicing clinicians and staff, clinical investigators
Suggested topics: Demographics, clinical presentation, diagnostic testing, patient management issues/insights, patterns in clinical complications, difficult cases
COVID-19 Considerations for Basic and Translational Research Forum
Purpose: Conversations directly relevant to research
Audience: Laboratory and translational scientists
Suggested topics: Data sharing, emerging literature, sample/tissue collection, model/reagent development, opportunities for collaboration, translational insights, research hypotheses
SITC has compiled resources from a variety of sources for oncology professionals to access rapidly changing information on the COVID-19 pandemic. These links, reviewed and deemed relevant by SITC, capture updates from external organizations and will be updated on a regular basis as new resources become available.
Explore Additional Resources
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com